Bial, an innovation-driven biopharmaceutical company, today announced the launch of KYNMOBI ® (apomorphine hydrochloride) in the United Kingdom, the first sublingual film indicated for the ...
Patients should receive training on the proper use of the delivery device prior to starting treatment. The Food and Drug Administration (FDA) has approved Onapgo™ (apomorphine hydrochloride [HCl]) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback